Gene DEAF1 Identified as Key Driver of Age-Related Muscle Decline
Researchers at Duke-NUS Medical School have identified the gene DEAF1 as a primary driver of age-related muscle weakness. As individuals age, DEAF1 levels rise, disrupting the mTORC1 signaling pathway and causing the accumulation of damaged proteins in muscle cells. The study, published in PNAS, demonstrates that exercise can reverse this process by lowering DEAF1 levels and restoring cellular balance. While the findings were observed in fruit flies and mice, they suggest that targeting this gene could eventually lead to therapies for those unable to exercise, though human application remains unproven.
Key points
- A team from Duke-NUS Medical School, Singapore General Hospital, and Cardiff University identified DEAF1 as a critical regulator of muscle aging.
- Aging causes DEAF1 levels to increase, which overactivates the mTORC1 pathway, leading to the buildup of defective proteins and muscle weakness.
- Exercise counteracts this by activating regulatory proteins that lower DEAF1, allowing muscle cells to clear damaged components and repair themselves.
- Experiments in fruit flies and mice showed that reducing DEAF1 restores muscle strength, indicating an evolutionarily conserved mechanism.
- The study notes that if DEAF1 levels become too high or protective FOXO proteins too low, exercise may no longer be sufficient to restore muscle function.
- Future therapies might mimic the molecular effects of exercise by targeting DEAF1, potentially helping individuals who cannot engage in physical activity.
Background
This discovery builds on recent findings regarding physical fitness trajectories. A Swedish study noted earlier this month that aerobic fitness peaks around age 35, with decline accelerating thereafter, though exercise can slow this loss. Additionally, recent research from Texas A&M University highlighted that creatine supplementation can increase muscle mass in older adults even without exercise, suggesting multiple pathways exist to combat age-related muscle loss. The current study provides a specific molecular mechanism for how physical activity intervenes in this decline.
How outlets are covering it
The primary source, ScienceDaily, emphasizes the specific molecular mechanism involving DEAF1 and mTORC1, highlighting the limitations of exercise when cellular damage is too severe. In contrast, the secondary source, Deccan Herald, takes a broader public health approach, focusing on 'inflammageing' and the general life-extending benefits of physical activity, citing a Finnish twin study. While ScienceDaily focuses on the cellular 'cleanup' process, Deccan Herald frames exercise as a low-cost medicine for longevity, without detailing the specific gene involved.
Why it matters
Understanding the DEAF1 mechanism offers a potential pathway for developing treatments for sarcopenia (age-related muscle loss) that do not rely solely on physical activity. This is particularly significant for aging populations, such as Singapore's, where maintaining muscle health is crucial for independence and reducing healthcare burdens. It also explains why some older adults may not respond well to exercise, pointing toward personalized medical interventions.
What to watch
Researchers will need to determine if manipulating DEAF1 is safe and effective in humans. While the current study was conducted in animal models, future clinical trials may explore therapies that mimic the molecular benefits of exercise for individuals unable to engage in physical activity due to illness or injury.
Want the full story? Read the original reporting
Read on Science Daily